New devices

Highlights of the Scottsdale Interventional Forum 2014, How-to Symposiums: Advances in Chronic Total Occlusion Therapy

02/01/2015

Michael A. Kutcher , MD, FACC, FSCAI;

Ashish Pershad , MD;

Mohamad Lazkani , MD;

David G. Rizik , MD, FACC, FSCAI;

Moneer Eddin , MD;

William L. Lombardi , MD;

The tenth annual Scottsdale Interventional Forum (SIF), which took place in Scottsdale, Arizona from March 5-8, 2014, brought together some of the leading experts in CTO-PCI. Topics discussed included review of the diagnostic coronary...

The tenth annual Scottsdale...

02/01/2015

Journal of Invasive Cardiology

Percutaneous Transfemoral Closure of a Pseudoaneurysm at the Left Ventricular Apical Access Site for Transcatheter Aortic Valve Implantation

02/01/2015

Ashkan Karimi , MD;

Thomas M. Beaver , MD, MPH;

James C. Fudge Jr., MD, MHS;

This case report illustrates a left ventricular pseudoaneurysm that developed at the transapical access site for transcatheter aortic valve implantation and was successfully excluded percutaneously through a femoral approach using an...

This case report illustrates a...

02/01/2015

Journal of Invasive Cardiology

A Q&A For Labs With Physicians Performing Radial Access: Bifurcation Lesion

12/05/2014

Zaheed Tai , MD, DO, FACC, FSCAI;

Orlando Marrero , RCIS, MBA;

The physicians at our institute use a 7 French (Fr) system for bifurcation lesions. What are the limitations of bifurcation lesions in a radial approach?

The physicians at our institute...

12/05/2014

Cath Lab Digest

Technology Pulse

Use Your Own Wire When Measuring FFR: The Catheter-Based ACIST RXi Rapid Exchange FFR System

11/05/2014

Alan J. Simons , MD, FACC, FSCAI, FACP;

Ronald P. Caputo , MD, FACC, FSCAI;

Once the wire is in place, I have yet to do a case where I have not been able to cross with the catheter. It is a much more user-friendly device than the wire-based systems.

Once the wire is in place, I...

11/05/2014

Cath Lab Digest

Technology Pulse

The Drug-Coated Balloon: Not Just a Balloon

11/05/2014

Fadi Saab , MD, FACC, FSCAI;

Larry J. Diaz-Sandoval , MD;

Jihad A. Mustapha , MD, FACC, FSCAI;

The DCB represents a technology that is able to carry and deliver an anti-proliferative drug to the arterial wall at the same time the mechanical treatment is provided to the obstructive atherosclerotic plaque. Understanding this apparently...

The DCB represents a technology...

11/05/2014

Cath Lab Digest

Clinical and Industry News

FDA Clears New Mechanical Blood Clot Removal System for Coronary and Peripheral Vasculature

10/15/2014

Control Medical Technology, Park City, Utah, announced the FDA cleared, and the company began shipping, the new Aspire RX-LP6 Rapid-Exchange Mechanical Thrombectomy System to remove fresh blood clots and emboli from coronary and peripheral...

Control Medical Technology, Park...

10/15/2014

Cath Lab Digest

Review

Endovascular Therapy for Treatment of Resistant Hypertension: Emerging Controversies and Technical Evolution

06/04/2013

Krishna J. Rocha-Singh , MD, FACC;

Despite encouraging early observations of renal denervation for treatment-resistant hypertension, recent reports in larger patient cohorts have suggested higher than initially reported nonresponder rates. Industry has responded with rapid...

Despite encouraging early...

06/04/2013

Vascular Disease Management

Case Report

Cardiogenic Shock: From Reperfusion to Revascularization and Hemodynamic Support

02/02/2010

Amar R. Chadaga, MD, Jamil B. Dihu, MD, Timothy A. Sanborn, MD

Amar R. Chadaga, MD, Jamil B. Dihu, M...

Cardiogenic shock represents the most ominous challenge of acute myocardial infarction (AMI), with an incidence of 8–9% and a mortality rate approaching 50%. The majority of cases of cardiogenic shock are secondary to AMI complicated by left...

Cardiogenic shock represents the...

02/02/2010

Vascular Disease Management